• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019-2020 年美国肺癌发病率:COVID-19 大流行的潜在影响。

Lung cancer incidence, 2019-2020, United States: The potential impact of the COVID-19 pandemic.

机构信息

Epidemic Intelligence Service, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA 30341, USA; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA 30341, USA.

Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA 30341, USA.

出版信息

Ann Epidemiol. 2024 Oct;98:44-50. doi: 10.1016/j.annepidem.2024.08.005. Epub 2024 Aug 26.

DOI:10.1016/j.annepidem.2024.08.005
PMID:39197807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11387122/
Abstract

PURPOSE

Cancer incidence declined during the COVID-19 pandemic in part due to health care delivery challenges. We examined the impact of the COVID-19 pandemic on changes in lung cancer incidence.

METHODS

We used 2019-2020 US Cancer Statistics data from 49 cancer registries covering 97 % of the US population. We calculated the number of new lung cancer diagnoses in 2019 and 2020, age-adjusted lung cancer incidence rates per 100,000 persons, and 2019-to-2020 % changes in incidence rates. We also calculated number and percentage of new lung cancer diagnoses by month and stage at diagnosis.

RESULTS

The age-adjusted lung cancer incidence rate per 100,000 persons was 47.9 in 2019 vs. 41.4 in 2020-a 13.6 % decrease. Differences in the percentage change in incidence rates were observed by age, race and ethnicity, US census region, histology, and stage at diagnosis. A higher percentage of people were diagnosed at distant stage in 2020 than 2019.

CONCLUSIONS

This report provides new insight into subgroups that experienced the greatest decline in observed lung cancer incidence during the first year of the COVID-19 pandemic. The findings can be used to inform intervention efforts to improve lung cancer screening, diagnosis, and treatment.

摘要

目的

由于医疗保健服务方面的挑战,COVID-19 大流行期间癌症发病率有所下降。本研究旨在探讨 COVID-19 大流行对肺癌发病率变化的影响。

方法

本研究使用了来自 49 个癌症登记处的 2019-2020 年美国癌症统计数据,覆盖了美国 97%的人口。我们计算了 2019 年和 2020 年的新肺癌诊断病例数、每 10 万人年龄调整后的肺癌发病率以及发病率的 2019-2020 年变化百分比。我们还按月和诊断时的分期计算了新肺癌诊断病例的数量和百分比。

结果

2019 年每 10 万人年龄调整后的肺癌发病率为 47.9,2020 年为 41.4,下降了 13.6%。不同年龄、种族和民族、美国人口普查区、组织学和诊断时的分期观察到发病率变化百分比存在差异。2020 年远处分期诊断的患者比例高于 2019 年。

结论

本报告为了解 COVID-19 大流行第一年观察到的肺癌发病率下降最大的亚组提供了新的见解。这些发现可用于为改善肺癌筛查、诊断和治疗提供干预措施的信息。

相似文献

1
Lung cancer incidence, 2019-2020, United States: The potential impact of the COVID-19 pandemic.2019-2020 年美国肺癌发病率:COVID-19 大流行的潜在影响。
Ann Epidemiol. 2024 Oct;98:44-50. doi: 10.1016/j.annepidem.2024.08.005. Epub 2024 Aug 26.
2
COVID-19 and Rates of Cancer Diagnosis in the US.COVID-19 与美国癌症诊断率。
JAMA Netw Open. 2024 Sep 3;7(9):e2432288. doi: 10.1001/jamanetworkopen.2024.32288.
3
Annual Report to the Nation on the Status of Cancer, featuring state-level statistics after the onset of the COVID-19 pandemic.《美国癌症现状年度报告》,重点介绍了新冠疫情爆发后的州级统计数据。
Cancer. 2025 May 1;131(9):e35833. doi: 10.1002/cncr.35833.
4
Analysis of lung cancer incidence, mortality trends, and smoking rates in Japan:1975-2022 with insights on the impact of COVID-19.日本肺癌发病率、死亡率趋势及吸烟率分析:1975 - 2022年,并探讨新冠疫情的影响
Int J Clin Oncol. 2025 Feb;30(2):199-209. doi: 10.1007/s10147-025-02695-4. Epub 2025 Jan 16.
5
Recovery From COVID-19-Related Disruptions in Cancer Detection.从与新冠病毒相关的癌症检测中断中恢复。
JAMA Netw Open. 2024 Oct 1;7(10):e2439263. doi: 10.1001/jamanetworkopen.2024.39263.
6
Racial and regional disparities in lung cancer incidence.肺癌发病率的种族和地区差异。
Cancer. 2012 Apr 1;118(7):1910-8. doi: 10.1002/cncr.26479. Epub 2011 Sep 14.
7
Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries.2020 - 2021年新冠疫情期间北欧国家癌症发病率和分期的变化。
Acta Oncol. 2025 Feb 12;64:257-266. doi: 10.2340/1651-226X.2025.42079.
8
Rates of newly diagnosed breast cancer at commission on cancer facilities during the early phase of the COVID-19 pandemic.在 COVID-19 大流行的早期阶段,癌症委员会设施中新诊断出的乳腺癌的发病率。
Cancer Med. 2024 Jan;13(1):e6874. doi: 10.1002/cam4.6874. Epub 2023 Dec 22.
9
Changes in cancer incidence rates by stage during the COVID-19 pandemic in the US.美国新冠疫情期间各阶段癌症发病率的变化。
Int J Cancer. 2024 Mar 1;154(5):786-792. doi: 10.1002/ijc.34758. Epub 2023 Nov 16.
10
COVID-19 impact on incidence and stage at diagnosis of five prominent cancers: A French cancer registry-based study.COVID-19 对五种主要癌症发病和诊断阶段的影响:一项基于法国癌症登记的研究。
J Epidemiol Popul Health. 2024 Oct;72(5):202555. doi: 10.1016/j.jeph.2024.202555. Epub 2024 Jul 4.

引用本文的文献

1
National adoption of robotic-assisted thoracoscopic surgery for oncologic lung resections.全国范围内采用机器人辅助胸腔镜手术进行肿瘤性肺切除。
J Robot Surg. 2025 Sep 4;19(1):557. doi: 10.1007/s11701-025-02727-1.
2
Changes in the Epidemiology of Thoracic and Cardiovascular Diseases in Korea During the COVID-19 Pandemic: A Nationwide Analysis.COVID-19大流行期间韩国胸心血管疾病流行病学变化:一项全国性分析
J Clin Med. 2024 Nov 22;13(23):7059. doi: 10.3390/jcm13237059.

本文引用的文献

1
Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018-2022.预防保健服务的使用与新发慢性病诊断:利用 PCORnet 数据识别美国 2018-2022 年的新兴趋势。
Prev Chronic Dis. 2024 Jul 3;21:E49. doi: 10.5888/pcd21.230415.
2
Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.美国在 COVID-19 大流行的前 10 个月未确诊的癌症病例。
JAMA Oncol. 2024 Apr 1;10(4):500-507. doi: 10.1001/jamaoncol.2023.6969.
3
Cancer and COVID-19: US cancer incidence rates during the first year of the pandemic.癌症与 COVID-19:大流行第一年美国癌症发病率。
J Natl Cancer Inst. 2024 Feb 8;116(2):208-215. doi: 10.1093/jnci/djad205.
4
Annual Report to the Nation on the Status of Cancer, part 2: Early assessment of the COVID-19 pandemic's impact on cancer diagnosis.《全国癌症报告》第二部分:早期评估 COVID-19 大流行对癌症诊断的影响。
Cancer. 2024 Jan 1;130(1):117-127. doi: 10.1002/cncr.35026. Epub 2023 Sep 27.
5
Impact on the Volume of Pathology Reports Before and During the COVID-19 Pandemic in SEER Cancer Registries.SEER 癌症登记处 COVID-19 大流行前后对病理报告数量的影响。
Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1591-1598. doi: 10.1158/1055-9965.EPI-23-0066.
6
Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic.解读癌症发病趋势:新冠疫情带来的挑战。
J Natl Cancer Inst. 2023 Sep 7;115(9):1109-1111. doi: 10.1093/jnci/djad086.
7
Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.医疗保险参保者在 COVID-19 大流行期间的乳腺癌和肺癌筛查。
JAMA Netw Open. 2023 Feb 1;6(2):e2255589. doi: 10.1001/jamanetworkopen.2022.55589.
8
Lung Cancer Screening Rates During the COVID-19 Pandemic.新冠疫情期间的肺癌筛查率
Chest. 2022 Feb;161(2):586-589. doi: 10.1016/j.chest.2021.07.030. Epub 2021 Jul 21.
9
Small-cell lung cancer.小细胞肺癌。
Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0.
10
Changes in Lung Cancer Treatment as a Result of the Coronavirus Disease 2019 Pandemic.由于 2019 年冠状病毒病大流行,肺癌治疗的变化。
JAMA Oncol. 2020 Nov 1;6(11):1805-1806. doi: 10.1001/jamaoncol.2020.4408.